Albers P, Wiegel T, Schmidberger H, Bussar-Maatz R, Härter M, Kristiansen G, Martus P, Meisner C, Wellek S, Grozinger K, Renner P, Burmester M, Schneider F, Stöckle M. Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial. World J Urol. 2021 39(1):65-72. Epub 2020 Mar 18.
Wellek S. Testing for goodness rather than lack of fit of continuous probability distributions. PLoS ONE. 2021 16(9):e0256499.
Wellek S, Blettner M. Is the p-Value a Suitable Basis for the Construction of Measures of Evidence? Comment on “The Role of p-Values in Judging the Strength of Evidence and Realistic Replication Expectations”. Statistics Biopharm Res. 2021 13(1):28-29.